Announcements and Notices - [Change in Auditors]

JW (Cayman) Therapeutics Co. Ltd operates as a clinical stage therapy platform company. The Company offers developing, manufacturing and commercializing breakthrough cell-based immunotherapies forhematological cancers and solid tumors. JW (Cayman) Therapeutics provides services in China.

Change Of Auditor

Financial Statements/ESG Information - [Interim/Half-Year Report]

2024 Interim Report

Announcements and Notices - [Other - Miscellaneous / Share Scheme]

Grant Of Share Options And Grant Of Restricted Share Units

Announcements and Notices - [List of Directors and their Role and Function]

List Of Directors And Their Roles And Functions

Announcements and Notices - [Change in Directors or of Important Executive Functions or Responsibilities / Change of Audit Committee Member / Change of Remuneration Committee Member]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

JW Therapeutics (2126 HK)

Change Of Auditor

2024 Interim Report

Grant Of Share Options And Grant Of Restricted Share Units

List Of Directors And Their Roles And Functions

Change Of Independent Non-Executive Directors And Change Of Composition Of Board Committees

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)